Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 32 results.
User Information
Export Records
  1. 1.   The Degradation of Botulinum Neurotoxin Light Chains Using PROTACs
  2. Tsai,Yien Che; Kozar, Loren; Mawi, Zo P; Ichtchenko, Konstantin; Shoemaker, Charles B; McNutt, Patrick M; Weissman,Allan
  3. International Journal of Molecular Sciences. 2024, Jul 08; 25(13):
  1. 2.   Simple monocyclic pyrimidine analogs as microtubule targeting agents binding to the colchicine site
  2. Choudhary, Shruti; Kaku, Krishna; Robles, Andrew J; Hamel,Ernest; Mooberry, Susan L; Gangjee, Aleem
  3. Bioorganic & Medicinal Chemistry. 2023, Feb 24; 82: 117217.
  1. 3.   µ-Conotoxins Targeting the Human Voltage-Gated Sodium Channel Subtype NaV1.7
  2. McMahon, Kirsten L; Tran, Hue N T; Deuis, Jennifer R; Craik, David J; Vetter, Irina; Schroeder, Christina I
  3. Toxins. 2022, Aug 30; 14(9):
  1. 4.   Environmental Pollutants, Mucosal Barriers, and Pathogen Susceptibility; The Case for Aflatoxin B-1 as a Risk Factor for HIV Transmission and Pathogenesis
  2. Madeen,Erin; Maldarelli,Frank; Groopman, John D.
  3. Pathogens. 2021, Sep 23; 10(10):
  1. 5.   Mini-Factor H Modulates Complement-Dependent IL-6 and IL-10 Release in an Immune Cell Culture (PBMC) Model: Potential Benefits Against Cytokine Storm
  2. Kozma, Gergely Tibor; Mészáros, Tamás; Bakos, Tamás; Hennies, Mark; Bencze, Dániel; Uzonyi, Barbara; Gyorffy, Balázs; Cedrone,Edward; Dobrovolskaia,Marina; Józsi, Mihály; Szebeni, János
  3. Frontiers in Immunology. 2021, Apr 28; 12: 642860.
  1. 6.   Generation of a Transgenic BALB/c Mouse Line With Selective Expression of Human Mesothelin in Thyroid Gland: Application in Mesothelin-targeted Immunotherapy
  2. Bera, Tapan K.; Liu, Wenlong; Leshem, Jasmin; King, Emily; Kozlov,Serguei; Pastan, Ira
  3. Journal of immunotherapy (Hagerstown, Md. : 1997). 2019, May; 42(4): 119-125.
  1. 7.   Nanoparticle physicochemical properties determine the activation of intracellular complement
  2. Ilinskaya, Anna N.; Shah, Ankit; Enciso, Alan E.; Chan,King; Kaczmarczyk,Jan; Blonder,Josip; Simanek, Eric E.; Dobrovolskaia,Marina
  3. Nanomedicine : nanotechnology, biology, and medicine. 2019, APR; 17: 266-275.
  1. 8.   Acute physiological changes caused by complement activators and amphotericin B-containing liposomes in mice
  2. Orfi, Erik; Meszaros, Tamas; Hennies, Mark; Fulop, Tamas; Dezsi, Laszlo; Nardocci, Alexander; Rosivall, Laszlo; Hamar, Peter; Neun, Barry; Dobrovolskaia, Marina; Szebeni, Janos; Szenasi, Gabor
  3. International journal of nanomedicine. 2019, Feb 26; 14: 1563-1573.
  1. 9.   Embryonic stem cell-derived motoneurons provide a highly sensitive cell culture model for botulinum neurotoxin studies, with implications for high-throughput drug discovery
  2. Kiris, E.; Nuss, J. E.; Burnett, J. C.; Kota, K. P.; Koh, D. C.; Wanner, L. M.; Torres-Melendez, E.; Gussio, R.; Tessarollo, L.; Bavari, S.
  3. Stem Cell Research. 2011, May; 6(3): 195-205.
  1. 10.   Targeting botulinum neurotoxin persistence by the ubiquitin-proteasome system
  2. Tsai, Y. C.; Maditz, R.; Kuo, C. L.; Fishman, P. S.; Shoemaker, C. B.; Oyler, G. A.; Weissman, A. M.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2010, Sep; 107(38): 16554-16559.
  1. 11.   Structural Model of the Pre-pore Ring-like Structure of Panton-Valentine Leukocidin: Providing Dimensionality to Biophysical and Mutational Data
  2. Aman, M. J.; Karauzum, H.; Bowden, M. G.; Nguyen, T. L.
  3. Journal of Biomolecular Structure & Dynamics. 2010, Aug; 28(1): 1-12.
  1. 12.   Temporal characteristics of botulinum neurotoxin therapy
  2. Lebeda, F. J.; Cer, R. Z.; Stephens, R. M.; Mudunuri, U.
  3. Expert Review of Neurotherapeutics. 2010, Jan; 10(1): 93-103.
  1. 13.   Quassinoid inhibition of AP-1 function does not correlate with cytotoxicity or protein synthesis inhibition
  2. Beutler, J. A.; Kang, M. I.; Robert, F.; Clement, J. A.; Pelletier, J.; Colburn, N. H.; McKee, T. C.; Goncharova, E.; McMahon, J. B.; Henrich, C. J.
  3. Journal of Natural Products. 2009, Mar 27; 72(3): 503-6.
  1. 14.   An insight into the sialome of the oriental rat flea, Xenopsylla cheopis (Rots)
  2. Andersen, J. F.; Hinnebusch, B. J.; Lucas, D. A.; Conrads, T. P.; Veenstra, T. D.; Pham, V. M.; Ribeiro, J. M. C.
  3. Bmc Genomics. 2007, Apr; 8
  1. 15.   An activity-dependent assay for ricin and related RNA N-glycosidases based on electrochemiluminescence
  2. Keener, W. K.; Rivera, V. R.; Young, C. C.; Poli, M. A.
  3. Analytical Biochemistry. 2006, Oct; 357(2): 200-207.
  1. 16.   Anthrax biosensor, protective antigen ion channel asymmetric blockade
  2. Halverson, K. M.; Panchal, R. G.; Nguyen, T. L.; Gussio, R.; Little, S. F.; Misakian, M.; Bavari, S.; Kasianowicz, J. J.
  3. Journal of Biological Chemistry. 2005, OCT 7; 280(40): 34056-34062.
  1. 17.   Transcriptional regulator CTCF controls human interleukin 1 receptor-associated kinase 2 promoter
  2. Kuzmin, I.; Geil, L.; Gibson, L.; Cavinato, T.; Loukinov, D.; Lobanenkov, V.; Lerman, M. I.
  3. Journal of Molecular Biology. 2005, FEB 18; 346(2): 411-422.
  1. 18.   Quantitative profiling of the detergent-resistant membrane proteome of Iota-b toxin induced Vero cells
  2. Blonder, J.; Hale, M. L.; Chan, K. C.; Yu, L. R.; Lucas, D. A.; Conrads, T. P.; Zhou, M.; Popoff, M. R.; Issaq, H. J.; Stiles, B. G.; Veenstra, T. D.
  3. Journal of Proteome Research. 2005, MAR-APR; 4(2): 523-531.
  1. 19.   A new, structurally nonredundant, diverse data set of protein-protein interfaces and its implications
  2. Keskin, O.; Tsai, C. J.; Wolfson, H.; Nussinov, R.
  3. Protein Science. 2004 13(4): 1043-1055.
  1. 20.   A potent anti-HIV immunotoxin blocks spreading infection by primary HIV type 1 isolates in multiple cell types
  2. Lueders, K. K.; De Rosa, S. C.; Valentin, A.; Pavlakis, G. N.; Roederer, M.; Hamer, D. H.
  3. Aids Research and Human Retroviruses. 2004 20(2): 145-150.
  1. 21.   Small molecule toxins targeting tumor receptors
  2. Dyba, M.; Tarasova, N. I.; Michejda, C. J.
  3. Current Pharmaceutical Design. 2004 10(19): 2311-2334.
  1. 22.   Cancer-specific ligands identified from screening of peptide-display libraries
  2. Mori, T.
  3. Current Pharmaceutical Design. 2004 10(19): 2335-2343.
  1. 23.   Therapeutic advantage from combining paclitaxel with the hypoxia-selective cytotoxin NLCQ-1 in murine tumor- or human xenograft-bearing mice
  2. Papadopoulou, M. V.; Ji, M.; Ji, X. H.; Bloomer, W. D.; Hollingshead, M. G.
  3. Cancer Chemotherapy and Pharmacology. 2002 50(6): 501-508.
  1. 24.   N-nitroso compounds and mutagens in Chinese fermented (sour) corn pancakes
  2. Groves, F. D.; Issaq, H.; Fox, S.; Jeffrey, A. M.; Whysner, J.; Zhang, L.; You, W. C.; Fraumeni, J. F.
  3. Journal of AOAC International. 2002 85(5): 1052-1056.
  1. 25.   Preparation of recombinant RNase single-chain antibody fusion proteins
  2. Newton, D. L.; Rybak, S. M.
  3. Molecular Biotechnology. 2002 20(1): 63-76.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel